Increased monocyte procoagulant activity (tissue factor) in patients with essential mixed cryoglobulinemia. 1986

A Pietra, and M L Paracchini, and A Gibelli, and G Bonfardeci, and M Venturino, and G D'Amico, and N Semeraro

Procoagulant activity (PCA) of peripheral blood mononuclear cells was studied in vitro in 14 consecutive patients with essential mixed cryoglobulinemia (EMC). Mononuclear cells tested immediately after isolation expressed significantly higher PCA than cells from a matched control group (P less than 0.01). PCA generated by patients' cells after incubation at 37 degrees C for four hours without any stimulant was significantly higher than that produced by control cells (P less than 0.001). Lower mononuclear cell PCA was observed in the subgroup of patients treated with low doses of prednisone than in untreated patients. In two patients given high-dosage prednisone, cell PCA was markedly reduced. These findings suggest that mononuclear cells may be activated for PCA production in vivo by cryoglobulins or other unknown stimuli. Mononuclear phagocytes, by producing PCA in vivo, might be directly implicated in the local fibrin deposition in tissue lesions of EMC.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D001779 Blood Coagulation Factors Endogenous substances, usually proteins, that are involved in the blood coagulation process. Clotting Factor,Coagulation Factors,Blood Coagulation Factor,Clotting Factors,Coagulation Factor,Coagulation Factor, Blood,Coagulation Factors, Blood,Factor, Coagulation,Factors, Coagulation,Factor, Blood Coagulation,Factor, Clotting,Factors, Blood Coagulation,Factors, Clotting
D003449 Cryoglobulinemia A condition characterized by the presence of abnormal quantities of CRYOGLOBULINS in the blood. Upon cold exposure, these abnormal proteins precipitate into the microvasculature leading to restricted blood flow in the exposed areas. Cryoglobulinemias
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260 Female Females
D005337 Fibrin A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot. Antithrombin I
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Pietra, and M L Paracchini, and A Gibelli, and G Bonfardeci, and M Venturino, and G D'Amico, and N Semeraro
January 1990, Nouvelle revue francaise d'hematologie,
A Pietra, and M L Paracchini, and A Gibelli, and G Bonfardeci, and M Venturino, and G D'Amico, and N Semeraro
August 1996, Laboratory investigation; a journal of technical methods and pathology,
A Pietra, and M L Paracchini, and A Gibelli, and G Bonfardeci, and M Venturino, and G D'Amico, and N Semeraro
November 1999, Medicina clinica,
A Pietra, and M L Paracchini, and A Gibelli, and G Bonfardeci, and M Venturino, and G D'Amico, and N Semeraro
August 1978, Harefuah,
A Pietra, and M L Paracchini, and A Gibelli, and G Bonfardeci, and M Venturino, and G D'Amico, and N Semeraro
January 1983, Zbornik. Vojnomedicinska akademija (Yugoslavia),
A Pietra, and M L Paracchini, and A Gibelli, and G Bonfardeci, and M Venturino, and G D'Amico, and N Semeraro
May 2017, Mayo Clinic proceedings,
A Pietra, and M L Paracchini, and A Gibelli, and G Bonfardeci, and M Venturino, and G D'Amico, and N Semeraro
September 1982, Journal of clinical & laboratory immunology,
A Pietra, and M L Paracchini, and A Gibelli, and G Bonfardeci, and M Venturino, and G D'Amico, and N Semeraro
December 1990, Lancet (London, England),
A Pietra, and M L Paracchini, and A Gibelli, and G Bonfardeci, and M Venturino, and G D'Amico, and N Semeraro
November 1990, Journal of clinical & laboratory immunology,
A Pietra, and M L Paracchini, and A Gibelli, and G Bonfardeci, and M Venturino, and G D'Amico, and N Semeraro
June 2009, Thrombosis and haemostasis,
Copied contents to your clipboard!